| ADA | Anti-drug antibodies |
| ADARC | Aaron Diamond AIDS Research Center |
| ADE | Antibody-dependent enhancement |
| aIgA | GPI-anchored version of the same IgA |
| BHK | Baby Hamster Kidney |
| BLT | Bone Marrow-Liver-Thymus |
| bnAbs | Broadly neutralizing antibodies |
| CH | Constant domain of Heavy chains (CH1, CH2, CH3) |
| CHO | Chinese Hamster Ovary |
| circRNA | Circular RNA |
| CL | Constant domain of Light chains |
| DAF | Decay-accelerating factor |
| dIgA | IgA antibody dimers |
| DMG-PEG2k | 1,2-dimyristoyl-rac-glycero-3-methoxy(polyethylene glycol)-2000 |
| DOPE | 1,2-Dioleoyl-sn-glycero-3-phosphatidylethanolamine |
| DOTAP | 1,2-Dioleoyl-sn-glycero-3-trimethylammonium-propane |
| DSPC | 1,2-Distearoyl-sn-glycero-3-phosphocholine |
| DSPE-PEG2k | 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine-N-carboxy(polyethylene glycol)-2000 |
| EBOV | Ebola virus |
| EEV | Extracellular enveloped virion |
| EMCV | Encephalomyocarditis virus |
| EU | European Union |
| EUA | Emergency Use Authorization |
| Fab | Fragment antigen-binding |
| Fc | Fragment crystallizable |
| FcγRIV | Fcγ receptor IV |
| FDA | Food and Drug Administration |
| FP | Fusion peptide |
| G4S | poly-Glycine-Serine linker |
| GMII | Golgi α-mannosidase II |
| Gn | Glycoprotein N |
| GP | Glycoprotein |
| GPI | Glycosylphosphatidylinositol |
| hACE2 | Human angiotensin-converting enzyme 2 |
| HBsAg | Hepatitis B surface antigen |
| HBV | Hepatitis B virus |
| HC | Heavy Chain |
| HEK | Human Embryonic Kidney |
| HPV18 | Human papillomavirus type 18 |
| hFcRn | Human neonatal receptor for the Fc fragment of IgG |
| HIV | Human immunodeficiency virus |
| i.m. | intramuscular |
| i.n. | intranasal |
| i.p. | intraperitoneal |
| i.t. | intratracheal |
| i.v. | intravenous |
| ID | Identification Number |
| IFNAR | Interferon-α/β Receptor |
| IgA | Immunoglobulin A |
| IgG | Immunoglobulin G |
| IgM | Immunoglobulin M |
| IMV | Intracellular mature virion |
| IRES | Internal Ribosome Entry Site |
| JC | Joining chain |
| LA | M435L/N441A mutation |
| LC | Light Chain |
| LNPs | Lipid nanoparticles |
| LS | M428L/N434S mutation |
| M2e | Ectodomain of the influenza A virus M2 protein |
| MERS-CoV | Middle East respiratory syndrome coronavirus |
| MPXV | Mpox virus, or monkeypox virus |
| NA | Not Available |
| NIAID | National Institute of Allergy and Infectious Diseases |
| NSG mouse | NOD scid gamma mouse |
| nsP | Nonstructural protein |
| P2A peptide | Porcine Teschovirus-1 2A peptide |
| PBATE | Poly(butylene terephthalate-co-butylene adipate-co-ethylene terephthalate-co-ethylene adipate) |
| PEG | Polyethylene glycol |
| PRRs | Pattern recognition receptors |
| RBD | Receptor-binding domain |
| RIG-I | Retinoic acid-inducible gene 1 |
| RSV | Respiratory Syncytial Virus |
| RTC | Replication-transcription complex |
| S protein | Surface protein |
| saRNA | Self-amplifying RNA |
| SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 |
| SC | Single chain |
| SC-mRNA | Single-chain mRNA |
| scBCR-seq | Single B cell receptor sequencing |
| scFv | Single-chain Variable Fragment |
| scFv–Fc | Single-Chain Variable Fragment fused to the Fc region |
| scIgA | Single-chain IgA |
| SFTSV | Severe fever with thrombocytopenia syndrome virus |
| SHIV | Simian-Human Immunodeficiency Virus |
| sIgA | Secreted version of the same IgA |
| SUDV | Sudan virus |
| TLR | Toll-like receptors |
| TM | L234F/L235E/P331S triple mutation |
| UK | United Kingdom |
| US | United States |
| USAMRIID | United States Army Medical Research Institute of Infectious Diseases |
| UTRs | Untranslated regions |
| VACV | Vaccinia virus |
| VARV | Variola virus |
| VEEV | Venezuelan equine encephalitis virus |
| VH | Variable Heavy chain domain |
| VHH | Variable Heavy domain of Heavy chain (single-domain antibody) |
| VL | Variable Light chain domain |
| VRPs | Virus replicon particles |
| YTE | M252Y/S254T/T256E mutation |